Clinical Trial Update: An Efficacy and Safety Trial of Intravenous Zoledronic Acid in Infants Less Than One Year of Age, With Severe Osteogenesis Imperfecta [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluated the efficacy and safety of intravenous zoledronic acid in infants under one year with severe osteogenesis imperfecta; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteogenesis Imperfecta

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Shriners Hospitals for Children | Conditions: Osteogenesis Imperfecta | Phase 3 | Status: COMPLETED